A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Steroid-resistant nephrotic syndrome (SRNS) is the second most frequent cause of ESRD in the first two decades of life. Effective treatment is lacking. First insights into disease mechanisms came from identification of single-gene causes of SRNS. However, the frequency of single-gene causation and its age distribution in large cohorts are unknown. We performed exon sequencing of NPHS2 and WT1 for 1783 unrelated, international families with SRNS. We then examined all patients by microfluidic multiplex PCR and next-generation sequencing for all 27 genes known to cause SRNS if mutated. We detected a single-gene cause in 29.5% (526 of 1783) of families with SRNS that manifested before 25 years of age. The fraction of families in whom a single-gene cause was identified inversely correlated with age of onset. Within clinically relevant age groups, the fraction of families with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.4%), between 4 and 12 months old (49.7%), between 1 and 6 years old (25.3%), between 7 and 12 years old (17.8%), and between 13 and 18 years old (10.8%). For PLCE1, specific mutations correlated with age of onset. Notably, 1% of individuals carried mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS may be treatable in these individuals. Our study results should facilitate molecular genetic diagnostics of SRNS, etiologic classification for therapeutic studies, generation of genotype-phenotype correlations, and the identification of individuals in whom a targeted treatment for SRNS may be available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“among these were many gene products currently known to be associated with hereditary nephrotic syndrome (Sadowski et al., 2015).”
From A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes (2018) · cites this paper as Sadowski et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.-C., Niaudet, P., & Antignac, C. (2000) · Nature Genetics · doi:10.1038/74166 · Cited by 1,444
The spectrum of podocytopathies: A unifying view of glomerular diseases
Wiggins, R.-C. (2007) · Kidney International · doi:10.1038/sj.ki.5002222 · Cited by 757
Hinkes, B., Wiggins, R. C., Gbadegesin, R., Vlangos, C. N., Seelow, D., Nürnberg, G., Garg, P., Verma, R., Chaib, H., Hoskins, B. E., et al. (2006) · Nature Genetics · doi:10.1038/ng1918 · Cited by 569
Self-citationSmith, J. M., Stablein, D. M., Munoz, R., Hebert, D., & McDonald, R. A. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00704.x · Cited by 479
Hinkes, B. G., Mucha, B., Vlangos, C. N., Gbadegesin, R., Liu, J., Hasselbacher, K., Hangan, D., Ozaltin, F., Zenker, M., Hildebrandt, F., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-2164 · Cited by 444
Self-citationRuf, R. G., Lichtenberger, A., Karle, S. M., Haas, J. P., Anacleto, F. E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.-M., Mucha, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113552.59155.72 · Cited by 417
Self-citationCOQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
Heeringa, S. F., Chernin, G., Chaki, M., Zhou, W., Sloan, A. J., Ji, Z., Xie, L. X., Salviati, L., Hurd, T. W., Vega-Warner, V., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45693 · Cited by 398
Self-citationWeber, S., Gribouval, O., Esquivel, E. L., Morinière, V., Tête, M.-J., Legendre, C., Niaudet, P., & Antignac, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00776.x · Cited by 375
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
Ashraf, S., Gee, H. Y., Woerner, S., Xie, L. X., Vega-Warner, V., Lovric, S., Fang, H., Song, X., Cattran, D. C., Avila-Casado, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69000 · Cited by 341
Self-citationGetting a foothold in nephrotic syndrome
Somlo, S., & Mundel, P. (2000) · Nature Genetics · doi:10.1038/74139 · Cited by 271
Cited by
Items 101–200 of 651
Park, E., Ahn, Y. H., Kang, H. G., Yoo, K. H., Won, N. H., Lee, K. B., Moon, K. C., Seong, M., Gwon, T. R., Park, S. S., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.10.040 · Cited by 53
Consensus Guidelines on Management of Steroid-Resistant Nephrotic Syndrome
Vasudevan, A., Thergaonkar, R. W., Mantan, M., Sharma, J., Khandelwal, P., Hari, P., Sinha, A. P., Bagga, A., & Expert Group of Indian Society of Pediatric Nephrology (2021) · Indian Pediatrics · doi:10.1007/s13312-021-2262-y · Cited by 56
Drovandi, S., Lipska-Ziętkiewicz, B. S., Özaltın, F., Emma, F., Gülhan, B., Boyer, O., Trautmann, A., Ziętkiewicz, S., Xu, H. M., Shen, Q., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.02.040 · Cited by 54
Primary Coenzyme Q10 Deficiency: An Update
Mantle, D., Millichap, L. E., Castro‐Marrero, J., & Hargreaves, I. P. (2023) · Antioxidants · doi:10.3390/antiox12081652 · Cited by 62
Podocyte Depletion in Thin GBM and Alport Syndrome
Wickman, L. T., Hodgin, J. B., Wang, S. Q., Afshinnia, F., Kershaw, D. S., & Wiggins, R. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155255 · Cited by 51
Glomerular Diseases in Children
Wenderfer, S. E., & Gaut, J. P. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.09.005 · Cited by 63
Amar, A., Majmundar, A. J., Ullah, I., Afzal, A., Braun, D. A., Shril, S., Daga, A., Jobst‐Schwan, T., Ahmad, M., Sayer, J. A., et al. (2019) · Human Genetics · doi:10.1007/s00439-019-01978-x · Cited by 51
Self-citationKomers, R., Gipson, D. S., Nelson, P., Adler, S. G., Srivastava, T., Derebail, V. K., Meyers, K. E. C., Pérgola, P. E., MacNally, M. E., Hunt, J. L., et al. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.02.019 · Cited by 50
Miao, J., Vairo, F. P. E., Hogan, M. C., Erickson, S. B., Ters, M. E., Bentall, A., Kukla, A., Greene, E. L., Hernandez, L. H., Sethi, S. M., et al. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.01.037 · Cited by 59
Recurrent focal segmental glomerulosclerosis after kidney transplantation
Trachtman, R. A., Sran, S. S., & Trachtman, H. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3062-1 · Cited by 53
“generation sequencing to test for all known loci, nearly 30 % of children with steroid-resistant nephrotic syndrome and FSGS have a genetic cause for their disease [17].”
BackgroundPodometrics as a Potential Clinical Tool for Glomerular Disease Management
Kikuchi, M., Wickman, L. T., Hodgin, J. B., & Wiggins, R. C. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.04.004 · Cited by 51
Wuttke, M., Wong, C. S., Wühl, E., Epting, D., Luo, L., Hoppmann, A., Doyon, A., Li, Y., Sözeri, B., Thurn, D., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv342 · Cited by 52
Riedhammer, K. M., Braunisch, M. C., Günthner, R., Wagner, M., Hemmer, C., Strom, T. M., Schmaderer, C., Renders, L., Tasic, V. B., Gucev, Z. S., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.008 · Cited by 55
The formin INF2 in disease: progress from 10 years of research
Labat‐de‐Hoz, L., & Alonso, M. A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03550-7 · Cited by 53
Hurdles to the introduction of new therapies for immune-mediated kidney diseases
Anders, H., Jayne, D. R. W., & Rovin, B. H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.206 · Cited by 49
Bezdíčka, M., Štolbová, Š., Seeman, T., Cinek, O., Malina, M., Šimánková, N., Průhová, Š., & Zieg, J. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3950-2 · Cited by 48
Interventions for idiopathic steroid-resistant nephrotic syndrome in children
Liu, I. D., Willis, N. S., Craig, J. C., & Hodson, E. M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003594.pub6 · Cited by 48
Using the Drosophila Nephrocyte to Model Podocyte Function and Disease
Helmstädter, M., Huber, T. B., & Hermle, T. F. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00262 · Cited by 50
PLCE1 regulates the migration, proliferation, and differentiation of podocytes
Yu, S., Choi, W., Choi, Y. J., Kim, H., Hildebrandt, F., & Gee, H. Y. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0410-4 · Cited by 60
Self-citationKemper, M. J., Valentin, L., & van Husen, M. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3780-7 · Cited by 46
“The treatment and prognosis of SRNS has changed in recent decades; in addition, major advances in elucidating the pathogenesis of FSGS have been made and it is now clear many patients have single-gene mutations in structural proteins of the podocyte, such as podocin [1].”
BackgroundSelf-citationPark, E., Lee, C., Kim, N., Ahn, Y. H., Park, Y., Lee, J. H., Kim, S. H., Cho, M., Cho, H., Yoo, K., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9062013 · Cited by 46
“Previous reports [4,12,13] have shown that the mutation detection rate is inversely related to age at disease onset in patients with SRNS.”
BackgroundInfluentialUsing Population Genetics to Interrogate the Monogenic Nephrotic Syndrome Diagnosis in a Case Cohort
Sampson, M. G., Gillies, C. E., Robertson, C. C., Crawford, B. D., Vega-Warner, V., Otto, E. A., Kretzler, M., & Kang, H. M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050504 · Cited by 48
Self-citationRecent advances in understanding and treating nephrotic syndrome
Bierżyńska, A., & Saleem, M. A. (2017) · F1000Research · doi:10.12688/f1000research.10165.1 · Cited by 54
“The incidence of genetic disease in the population varies with age, and over 80% of patients presenting under the age of a year have an identifiable mutation 4,5 .”
Genotype–phenotype analysis of pediatric patients with WT1 glomerulopathy
Ahn, Y. H., Park, E. J., Kang, H. G., Kim, S. H., Cho, H. Y., Shin, J. I., Lee, J. H., Park, Y. S., Kim, K. S., Ha, I. S., et al. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3395-4 · Cited by 44
“The WT1 gene encodes the nuclear transcription factorWT1 [3], and is one of the genes that is commonly reported as mutated in pediatric patients with NS [1, 2, 4].”
BackgroundKidney disease in children: latest advances and remaining challenges
Bertram, J. F., Goldstein, S. L., Pape, L., Schaefer, F. S., Shroff, R. C., & Warady, B. A. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.219 · Cited by 43
Fu, Y., Zhu, J., Richman, A., Zhao, Z., Zhang, F., Ray, P. E., & Han, Z. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddw428 · Cited by 49
Tan, W., Lovric, S., Ashraf, S., Rao, J., Schapiro, D., Airik, M., Shril, S., Gee, H. Y., Baum, M. A., Daouk, G. H., et al. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3801-6 · Cited by 43
“Criteria for variant calling were applied, as previously described [14].”
InfluentialSelf-citationBartram, M. P., Habbig, S., Pahmeyer, C., Höhne, M., Weber, L. T., Thiele, H., Altmüller, J., Kottoor, N., Wenzel, A., Krüger, M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv638 · Cited by 50
“nephronophthisis complex represent the two most frequent causes of end-stage renal disease (ESRD) up to the age of 25 years (2,3).”
BackgroundLipska-Ziętkiewicz, B. S., Özaltın, F., Hölttä, T., Böckenhauer, D., Bérody, S., Levtchenko, E. N., Vivarelli, M., Webb, H., Haffner, D., Schaefer, F. S., et al. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0642-8 · Cited by 45
Aulicino, F., Pelosse, M., Toelzer, C., Capin, J., Ilegems, E., Meysami, P., Rollarson, R., Berggren, P., Dillingham, M. S., Schaffitzel, C., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac587 · Cited by 44
de Haan, A., Eijgelsheim, M., Vogt, L., Knoers, N. V. A. M., & de Borst, M. H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01264 · Cited by 47
Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia
Lipska-Ziętkiewicz, B. S., Gellermann, J., Boyer, O., Gribouval, O., Ziętkiewicz, S., Kari, J. A., Shalaby, M. A., Özaltın, F., Dusek, J., Melk, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180926 · Cited by 40
“The observed prevalence is identical to the one provided in a recent review of 1783 SRNS families who underwent genetic screening [6].”
ResultSelf-citationGenetic variants in the LAMA5 gene in pediatric nephrotic syndrome
Braun, D. A., Warejko, J. K., Ashraf, S., Tan, W., Daga, A., Schneider, R., Hermle, T. F., Jobst‐Schwan, T., Widmeier, E., Majmundar, A. J., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy028 · Cited by 41
“5% of cases with an onset of SRNS before age 25 years, a causative single-gene mutation could be identified [12].”
BackgroundSelf-citationClaus, L., Snoek, R., Knoers, N., & van Eerde, A. V. (2022) · American Journal of Medical Genetics. Part C, Seminars in Medical Genetics · doi:10.1002/ajmg.c.31995 · Cited by 37
Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible
Klaassen, I., Özgören, B., Sadowski, C. E., Möller, K., van Husen, M., Lehnhardt, A., Timmermann, K., Freudenberg, F., Helmchen, U. M., Oh, J. S., et al. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3109-3 · Cited by 39
Self-citationChung, C.-F., Kitzler, T. M., Kachurina, N., Pessina, K., Babayeva, S., Bitzan, M. M., Fj, K., Colmegna, I., Alachkar, N., Goodyer, P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216426 · Cited by 39
“In up to 50–70% of children under 1 year of age at the onset, and ~20% of children older than 1 year and adults with SRNS/FSGS, the disease can be attributed to mutations in genes that encode key proteins in the podocyte [3–6].”
Diffuse mesangial sclerosis in a PDSS2 mutation-induced coenzyme Q10 deficiency
Iványi, B., Rácz, G., Gál, P., Brinyiczki, K., Bódi, I., Kalmár, T., Maróti, Z., & Bereczki, C. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3814-1 · Cited by 38
A Review of Focal Segmental Glomerulosclerosis Classification With a Focus on Genetic Associations
Bonilla, M. A., Efe, O., Selvaskandan, H., Lerma, E. V., & Wiegley, N. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100826 · Cited by 48
“Sadowski et al 43 found a causative monogenetic cause in 21.4% of the cases with onset between 19-25 years’ age.”
BackgroundInfluentialGenetics of hereditary nephrotic syndrome: a clinical review
Ha, T.-S. (2017) · Korean Journal of Pediatrics · doi:10.3345/kjp.2017.60.3.55 · Cited by 38
Morello, W., Puvinathan, S., Puccio, G., Ghiggeri, G. M., Strologo, L. D., Peruzzi, L., Murer, L., Cioni, M., Guzzo, I., Cocchi, E., et al. (2019) · Journal of Nephrology · doi:10.1007/s40620-019-00660-9 · Cited by 38
Thomas, C. P., Mansilla, M. A., Sompallae, R. R., Mason, S. O., Nishimura, C., Kimble, M., Campbell, C. A., Kwitek, A. E., Darbro, B. W., Stewart, Z. A., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13970 · Cited by 37
The Genetics of Nephrotic Syndrome
Gbadegesin, R., & Rheault, M. N. (2015) · Journal of Pediatric Genetics · doi:10.1055/s-0035-1557109 · Cited by 48
The mutation-dependent pathogenicity ofNPHS2p.R229Q: A guide for clinical assessment
Mikó, Á., Menyhárd, D. K., Kaposi, A., Antignac, C., & Tory, K. (2018) · Human Mutation · doi:10.1002/humu.23660 · Cited by 40
“R229Q];[mut] (Al-Hamed et al., 2013; Berdeli et al., 2007; Bertelli et al., 2003; Buscher et al., 2010; Caridi et al., 2001; Chernin et al., 2010; Jungraithmayr et al., 2011; Karle et al., 2002; Lipska et al., 2013; Machuca et al., 2009; Megremis et al., 2009; Ruf et al., 2004; Sadowski et al., 2015; Santin et al., 20…”
BackgroundInfluentialMalakasioti, G., Iancu, D., Milovanova, A. M., Tsygin, A. N., Horinouchi, T., Nagano, C., Nozu, K., Kamei, K., Fujinaga, S., Iijima, K., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.02.022 · Cited by 37
Self-citationTan, W., & Airik, R. (2021) · Pediatric Nephrology · doi:10.1007/s00467-020-04914-8 · Cited by 38
Self-citationGenetics of childhood steroid-sensitive nephrotic syndrome
Karp, A. M., & Gbadegesin, R. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3456-8 · Cited by 36
“Depending on the population being studied, it is estimated that 2–30 % of all cases of SRNS are due to a single gene defect [31, 32].”
BackgroundHan, Q., Zhang, X., Ren, X., Zhou, H., Yin, Y., Wang, Z., Chen, H., Sun, L. Y., Tao, J., Han, Z., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.844709 · Cited by 36
“The impact of the differences in the genetic level to explain the mechanism of various rejection reactions has become the current mainstream (Sadowski et al., 2015; Chen et al., 2018; Haas et al., 2018).”
BackgroundFocal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations
Park, E., Kang, H. G., Choi, Y. H., Lee, K. B., Moon, K. C., Jeong, H. J., Nagata, M., & Cheong, H. I. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3657-9 · Cited by 35
Hughes, B. G., Harrison, P. M., & Hekimi, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-17564-y · Cited by 42
Cell biology and genetics of minimal change disease
Saleem, M. A., & Kobayashi, Y. (2016) · F1000Research · doi:10.12688/f1000research.7300.1 · Cited by 34
“Pathogenic mutations in MCD Familial cases are rather rare in MCD, therefore the genetic background of SSNS is largely unknown, while 23.6% of SRNS cases 10 and 29.5% of familial SRNS cases 11 are caused by gene mutation.”
BackgroundInfluentialEmerging therapeutics for the treatment of diabetic nephropathy
Brenneman, J. B., Hill, J., & Pullen, S. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.079 · Cited by 36
Podocyte number and density changes during early human life
Kikuchi, M., Wickman, L. T., Rabah, R. M., & Wiggins, R. C. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3564-5 · Cited by 34
“, ITGA3, ITGA4, and LAMB2) and coenzyme Q pathway synthesis proteins necessary to protect the huge lipid surface area of the podocyte from mitochondria-induced oxidant damage [12, 22, 40].”
BackgroundWarejko, J. K., Schueler, M., Vivante, A., Tan, W., Daga, A., Lawson, J. A., Braun, D. A., Shril, S., Amann, K., Somers, M. J. G., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10296 · Cited by 33
Self-citationDAAM2 Variants Cause Nephrotic Syndrome via Actin Dysregulation
Schneider, R., Deutsch, K., Hoeprich, G. J., Marquez, J., Hermle, T. F., Braun, D. A., Seltzsam, S., Kitzler, T. M., Mao, Y., Buerger, F., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.11.008 · Cited by 37
“Here, we describe the discovery of bi-allelic variants in DAAM2 as likely monogenic causes of SRNS in four distinct families with SRNS.”
InfluentialSelf-citationRecessive NOS1AP variants impair actin remodeling and cause glomerulopathy in humans and mice
Majmundar, A. J., Buerger, F., Forbes, T. A., Klämbt, V., Schneider, R., Deutsch, K., Kitzler, T. M., Howden, S. E., Scurr, M., Tan, K. S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe1386 · Cited by 38
Self-citationThe Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome
Canetta, P. A., & Radhakrishnan, J. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00078 · Cited by 33
Genetic tests in children with steroid-resistant nephrotic syndrome
Cheong, H. I. (2020) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.20.001 · Cited by 31
“As another example, in ethnic groups with a higher prevalence of NPHS2 mutations, the sum of mutations in three common diseasecausing genes (NPHS1, NPHS2, and WT1) account for over 70% of total mutations detected in pediatric patients with SRNS [3,5,33].”
BackgroundInfluentialQuantitative podocyte parameters predict human native kidney and allograft half-lives
Naik, A. S., Afshinnia, F., Cibrik, D. M., Hodgin, J. B., Wu, F., Zhang, M., Kikuchi, M., Wickman, L. T., Samaniego, M., Bitzer, M., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86943 · Cited by 33
Nagano, C., Nozu, K., Morisada, N., Yazawa, M., Ichikawa, D., Numasawa, K., Kourakata, H., Matsumura, C., Tazoe, S., Tanaka, R., et al. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1534-x · Cited by 30
“Targeted sequencing panels are especially useful for analyzing diseases with genetic heterogeneity, such as Bartter syndrome or steroid-resistant nephrotic syndrome, which have many different causative genes [2, 3].”
BackgroundNUP107 mutations in children with steroid-resistant nephrotic syndrome
Park, E., Ahn, Y. H., Kang, H. G., Miyake, N., Tsukaguchi, H., & Cheong, H. I. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw103 · Cited by 34
Gigante, M., Diella, S., Santangelo, L., Trevisson, E., Acosta, M. J., Amatruda, M., Finzi, G., Caridi, G., Murer, L., Accetturo, M., et al. (2017) · Clinical Genetics · doi:10.1111/cge.12960 · Cited by 29
“To the Editor: Genes involved in the coenzyme Q10 biosynthetic pathway (COQ2, COQ6, PDSS1, PDSS2 and ADCK4) are mutated in about 1% of steroid resistant nephrotic syndrome (SRNS) cases and are often associated with neurological symptoms (1, 2).”
BackgroundMultiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor
Savin, V. J., Sharma, M., Zhou, J., Genochi, D., Sharma, R., Srivastava, T., Ilahe, A., Budhiraja, P., Gupta, A., & McCarthy, E. T. (2017) · BioMed Research International · doi:10.1155/2017/6232616 · Cited by 32
“However, currently identified monogenic disorders account for a minority of cases [2], and the cause of podocyte dysfunction or loss leading to nephrotic syndrome is not known inmost patients.”
BackgroundGenomics Integration Into Nephrology Practice
Vairo, F. P. E., Prochnow, C. A., Kemppainen, J. L., Lisi, E. C., Steyermark, J. M., Kruisselbrink, T., Pichurin, P. N., Dhamija, R., Hager, M. M., Albadri, S. T., et al. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2021.04.014 · Cited by 30
Recurrence and Treatment after Renal Transplantation in Children with FSGS
Kang, H. G., Ha, I. S., & Cheong, H. I. (2016) · BioMed Research International · doi:10.1155/2016/6832971 · Cited by 29
Genetic Testing for Steroid-Resistant-Nephrotic Syndrome in an Outbred Population
Varner, J. D., Chryst-Stangl, M., Esezobor, C. I., Solarin, A. U., Wu, G., Lane, B. M., Hall, G., Abeyagunawardena, A. S., Matory, A., Hunley, T. E., et al. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00307 · Cited by 34
Malakasioti, G., Iancu, D., & Tullus, K. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04695-0 · Cited by 29
Renal genetics in Australia: Kidney medicine in the genomic age
Jayasinghe, K., Quinlan, C., Stark, Z., Patel, C., Mallawaarachchi, A. C., Wardrop, L., Kerr, P. G., Trnka, P., Mallett, A. J., & Collaborative, O. B. O. T. K. (2018) · Nephrology · doi:10.1111/nep.13494 · Cited by 30
“5%.(23) The advent of WES may have improved the diagnostic yield, with a recent study demonstrating a monogenic causative mutation in 15 out of 51 families who presented with suspected nephrolithiasis or nephrocalcinosis before the age of 25 years.”
BackgroundGene mutation analysis in 12 Chinese children with congenital nephrotic syndrome
Li, G., Cao, Q., Shen, Q., Sun, L., Zhai, Y., Liu, H., An, Y., & Xu, H. M. (2018) · BMC Nephrology · doi:10.1186/s12882-018-1184-y · Cited by 27
Genetic Testing in Pediatric Kidney Disease
Arora, V., Anand, K., & Verma, I. C. (2020) · The Indian Journal of Pediatrics · doi:10.1007/s12098-020-03198-y · Cited by 28
Dorison, A., Ghobrial, I. M., Graham, A. N., Peiris, T., Forbes, T. A., See, M., Das, M., Saleem, M. A., Quinlan, C., Lawlor, K. T., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022060707 · Cited by 30
Bagang, N., Gupta, K., Singh, G., Kanuri, S. H., & Mehan, S. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110470 · Cited by 33
Ogino, D., Hashimoto, T., Hattori, M., Sugawara, N., Akioka, Y., Tamiya, G., Makino, S., Toyota, K., Mitsui, T., & Hayasaka, K. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.122 · Cited by 33
Endoplasmic reticulum–retained podocin mutants are massively degraded by the proteasome
Serrano-Perez, M.-C., Tilley, F. C., Névo, F., Arrondel, C., Sbissa, S., Martin, G., Tory, K., Antignac, C., & Mollet, G. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001159 · Cited by 30
“A mutant allele encoding podocin with a p.R138Q amino acid substitution is the most frequent pathogenic variant in European and North American children, and the corresponding mutant protein is poorly expressed and retained in the endoplasmic reticulum both in vitro and in vivo.”
BackgroundInfluentialHashimoto, T., Harita, Y., Takizawa, K., Urae, S., Ishizuka, K., Miura, K., Horita, S., Ogino, D., Tamiya, G., Ishida, H., et al. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.05.1157 · Cited by 27
“A single mutation was identified in approximately 30% of a mostly pediatric SRNS cohort.(7,13,14) NPCs form an octagonal channel across the nuclear envelope that mediate nucleocytoplasmic transport.”
BackgroundJacobs-Cachá, C., Vergara, A., García-Carro, C., Agraz, I., Toapanta, N., Ariceta, G., Moreso, F., Serón, D., López-Hellín, J., & Soler, M. J. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa110 · Cited by 33
“Furthermore, routine whole-exome sequencing has allowed not only the description of >30 genes related to steroid resistance in nephrotic syndrome [11, 27, 28], but also discarding of other kidney diseases with proteinuria and FSGS, but from a totally different aetiology (i.”
BackgroundWeng, P. L., Majmundar, A. J., Khan, K., Lim, T. Y., Shril, S., Jin, G. Y., Musgrove, J., Wang, M., Ahram, D. F., Aggarwal, V. S., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.01.008 · Cited by 28
Self-citationSambharia, M., Rastogi, P., & Thomas, C. P. (2022) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31990 · Cited by 31
“…of monogenic FSGS appears to be higher with a lower age of disease onset with 20–30% of children with SRNS or FSGS having a genetic cause (Bierzynska et al., 2017; Nagano et al., 2020; Park et al., 2020; Sadowski et al., 2015; Trautmann et al., 2015; Wang et al., 2017; Warejko et al., 2018).”
BackgroundNephrology research—the past, present and future
Floege, J., MAK, R. H. K., Molitoris, B. A., Remuzzi, G., & Ronco, P. M. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.152 · Cited by 29
Mutation spectrum of genes associated with steroid-resistant nephrotic syndrome in Chinese children
Wang, Y. X., Dang, X., He, Q., Zhen, Y., He, X., Yi, Z.-W., & Zhu, K. (2017) · Gene · doi:10.1016/j.gene.2017.04.050 · Cited by 28
Feltran, L. D. S., Varela, P., da Silva, E. D., Veronez, C. L., Franco, M. D. C., Filho, Á. P. E. S., de Camargo, M. F. C., Nogueira, P. C. K., & Pesquero, J. B. (2017) · Transplantation · doi:10.1097/tp.0000000000001846 · Cited by 29
CoQ10-related sustained remission of proteinuria in a child with COQ6 glomerulopathy—a case report
Stańczyk, M. B., Bałasz–Chmielewska, I., Lipska-Ziętkiewicz, B. S., & Tkaczyk, M. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-4083-3 · Cited by 27
Treatment of Genetic Forms of Nephrotic Syndrome
Kemper, M. J., & Lemke, A. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00072 · Cited by 27
Self-citationMirioğlu, Ş., Çalışkan, Y., Özlük, Y., Dirim, A. B., İstemihan, Z., Akyıldız, A., Yazıcı, H., Türkmen, A., Kiliçaslan, İ., & Sever, M. Ş. (2019) · Kidney & Blood Pressure Research · doi:10.1159/000501827 · Cited by 26
Ishizuka, K., Miura, K., Hashimoto, T., Kaneko, N., Harita, Y., Yabuuchi, T., Hisano, M., Fujinaga, S., Omori, T., Yamaguchi, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91520-9 · Cited by 34
An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome
Horinouchi, T., Nozu, K., & Iijima, K. (2022) · Pediatric Nephrology · doi:10.1007/s00467-021-05401-4 · Cited by 31
NPHS2 mutations account for only 15 % of nephrotic syndrome cases
Guaragna, M. S., Lutaif, A. C. G. D. B., Piveta, C. S. C., de Souza, M. L., SOUZA, S. R. D., Henriques, T. B., Maciel‐Guerra, A. T., Belangero, V. M. S., Guerra‐Júnior, G., & de Mello, M. P. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0231-9 · Cited by 31
“carried out mainly in European and North American countries [3, 4, 14, 34, 35, 36].”
BackgroundPLCε1 regulates SDF-1α–induced lymphocyte adhesion and migration to sites of inflammation
Strazza, M., Azoulay‐Alfaguter, I., Peled, M., Smrcka, A. V., Skolnik, E. Y., Srivastava, S., & Mor, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612900114 · Cited by 26
Rood, I. M., Deegens, J. K., Lugtenberg, D., Bongers, E. M. H. F., & Wetzels, J. F. M. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.034 · Cited by 29
Treatment of steroid-resistant nephrotic syndrome in the genomic era
Bensimhon, A. R., Williams, A. E., & Gbadegesin, R. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-4093-1 · Cited by 29
Stone, H. K., Magella, B., & BENNETT, M. R. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00404 · Cited by 34
Australia and New Zealand renal gene panel testing in routine clinical practice of 542 families
Tanudisastro, H. A., Holman, K. J., Ho, G., Farnsworth, E., Fisk, K., Gayagay, T., Hackett, E. L., Jenkins, G., Krishnaraj, R. R., Lai, T., et al. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00184-x · Cited by 25
“Tubulopathies 60 30 44 SLC12A3 (13), CLCN5 (3), AGXT (2), HNF4A (2), SLC4A1 (2), SLC7A9 (2), AQP2 (1), ATP6V1B1 (1), CLCNKB (1), GRHPR (1), SCNN1A (1), SLC12A1 (1)”
Lane, B. M., Chryst-Stangl, M., Wu, G., Shalaby, M. A., Desoky, S. M. E., Middleton, C. C., Huggins, K., Sood, A., Ochoa, A., Malone, A. F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.152102 · Cited by 26
“JCI Insight 2022;7(2):e152102 https://doi.”
Self-citationConsensus guidelines on management of steroid resistant nephrotic syndrome
Bagga, A., Vasudevan, A., Thergaonkar, R. W., Mantan, M., Sharma, J., Khandelwal, P., Hari, P., & Sinha, A. P. (2021) · Asian Journal of Pediatric Nephrology · doi:10.4103/ajpn.ajpn_35_21 · Cited by 25
COL4A1 mutations as a potential novel cause of autosomal dominant CAKUT in humans
Kitzler, T. M., Schneider, R., Kohl, S., Kolvenbach, C. M., Connaughton, D. M., Dai, R., Mann, N., Nakayama, M., Majmundar, A. J., Wu, C. W., et al. (2019) · Human Genetics · doi:10.1007/s00439-019-02042-4 · Cited by 27
Self-citationDomingo-Gallego, A., Pybus, M., Madariaga, L., Piñero‐Fernández, J. A., González-Pastor, S., López-González, M., Simarro-Rueda, E., Quintanilla-Mata, M. L., Matoses-Ruipérez, M. L., Ejarque, L., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab285 · Cited by 24
“In a cohort of 1783 families with steroid-resistant nephrotic syndrome that manifested before 25 years of age, five families were reported to carry biallelic variants in the CUBN gene [9, 42].”
BackgroundNew Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid
Lin, D.-W., Chang, C., Hsu, Y., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073525 · Cited by 26
“These genetic/familial FSGS with single gene mutation usually express immunosuppressant resistance [83].”
BackgroundPanel sequencing distinguishes monogenic forms of nephritis from nephrosis in children
Schapiro, D., Daga, A., Lawson, J. A., Majmundar, A. J., Lovric, S., Tan, W., Warejko, J. K., Fessi, I., Rao, J., Airik, M., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy050 · Cited by 26
Self-citationAsharam, K., Bhimma, R., David, V. A., Coovadia, H. M., Qulu, W. P., Naicker, T., Gillies, C. E., Vega-Warner, V., Johnson, R. C., Limou, S., et al. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.07.017 · Cited by 24
“Mutations in NPHS2 were the most frequent cause of SRNS in children aged 1 to 18 (6% to 13% for different age groups).(14) Among families with SRNS and congenital NS enrolled in the PodoNet registry cohort, recessive mutations in NPHS2 were identified 138 of 1088 children (12.”
BackgroundSelf-citationWu, C. W., Mann, N., Nakayama, M., Connaughton, D. M., Dai, R., Kolvenbach, C. M., Kause, F., Ottlewski, I., Wang, C., Klämbt, V., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0844-z · Cited by 24
Self-citationHughes, E. P., Wang, X. X., Sabol, L., Barton, K., Hegde, S., Myakala, K., Krawczyk, E., Rosenberg, A. Z., & Levi, M. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00110.2025 · Cited by 29
Metadata
- Authors
- Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., Somers, M. J., Tan, W., Shril, S., Fessi, I., Lifton, R. P., Bockenhauer, D., El-Desoky, S., Kari, J. A., Zenker, M., Kemper, M. J., Mueller, D., Fathy, H. M., Soliman, N. A., & Hildebrandt, F.
- Affiliations
- Boston Children's Hospital (US)
- University of Michigan (US)
- Howard Hughes Medical Institute (US)
- King Abdul Aziz University Hospital (SA)
- Otto-von-Guericke-Universität Magdeburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Stiftung Charité (DE)
- Alexandria University (EG)
- Cairo University (EG)
- Corresponding author
- Sadowski, Carolin E.
- Lovric, Svjetlana
- Ashraf, Shazia
- Pabst, Werner L.
- Gee, Heon Yung
- Kohl, Stefan
- Engelmann, Susanne
- Fang, Humphrey
- Halbritter, Jan
- Somers, Michael J.
- Tan, Weizhen
- Shril, Shirlee
- Fessi, Inès
- Kemper, Markus J.
- Hildebrandt, Friedhelm
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-06
- Volume
- 26
- Issue
- 6
- Pages
- 1279-1289
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC4446877
- OpenAlex
- W2163605874
- Cited by
- 651
- References
- 41
- Citations by year
- 2026: 45 · 2025: 40 · 2024: 45 · 2023: 63 · 2022: 69 · 2021: 61 · 2020: 55 · 2019: 55 · 2018: 64 · 2017: 62 · 2016: 50 · 2015: 40
- FWCI
- 40.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Nephcure Foundation
- Kidney Research UK (RP45/2008)
- National Institutes of Health
- Manton Center for Orphan Disease Research, Boston Children's Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases (RC4-DK076683, P30DK079310, R01DK076683)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Oncology › Renal and related cancers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- steroid-resistant nephrotic syndrome, NPHS2, WT1, PLCE1, coenzyme Q10 biosynthesis, age of onset, genotype-phenotype correlation, molecular genetic diagnosis, pediatric kidney disease, end-stage renal disease
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Female, Genotype, Heterozygote, Humans, Infant, Male, Membrane Proteins, Middle Aged, Mutation, Nephrotic Syndrome, Pedigree, Phenotype, Retrospective Studies, Cohort Studies, Incidence, Genes, Wilms Tumor, Age of Onset, Risk Assessment, Genetic Predisposition to Disease, Intracellular Signaling Peptides and Proteins, Young Adult, Genetic Association Studies, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.